Sertraline
| CAS No. | 79617-96-2 |
|---|---|
| MDL No. | MFCD00865372 |
| MF | C17H17Cl2N |
| MW | 306.20 |
| InChI Key | VGKDLMBJGBXTGI-SJCJKPOMSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Sertraline is a tetralin derivative substituted at positions 1 and 4 with a methylamino group and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). It is a selective serotonin-reuptake inhibitor (SSRI) administered orally as the hydrochloride salt. Used as an antidepressant for treating depression, obsessive-compulsive disorder, panic disorder, and post-traumatic stress disorder, it is also a secondary amino compound, a dichlorobenzene, and a conjugate base of sertraline(1+). It derives from a tetralin hydride.
| CAS No. | 79617-96-2 |
|---|---|
| Product Name | Sertraline |
Biological Targets
SLC6A4
Associated Conditions
autism spectrum disorder·hepatitis C virus infection·panic disorder·cocaine dependence·postpartum depression·
* The information provided here is compiled from public sources and is for reference only.
